Michael Machiorlatti

1.2k total citations
33 papers, 214 citations indexed

About

Michael Machiorlatti is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Michael Machiorlatti has authored 33 papers receiving a total of 214 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Public Health, Environmental and Occupational Health and 5 papers in Hematology. Recurrent topics in Michael Machiorlatti's work include Cancer Immunotherapy and Biomarkers (5 papers), Acute Myeloid Leukemia Research (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). Michael Machiorlatti is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Acute Myeloid Leukemia Research (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). Michael Machiorlatti collaborates with scholars based in United States and Myanmar. Michael Machiorlatti's co-authors include Sara K. Vesely, Joshua Muscat, Hussein Assi, Allshine Chen, Nicolle M. Krebs, Hassan Hatoum, Sarbajit Mukherjee, Sami Ibrahimi, Pamela L. Kunz and Mohamad Cherry and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michael Machiorlatti

27 papers receiving 211 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Machiorlatti United States 8 108 59 30 29 27 33 214
Bernard Tawfik United States 9 158 1.5× 72 1.2× 24 0.8× 18 0.6× 41 1.5× 30 335
Dianlin Guo United States 7 91 0.8× 96 1.6× 10 0.3× 7 0.2× 25 0.9× 10 331
Ariel Yuhan Ong United Kingdom 9 107 1.0× 54 0.9× 13 0.4× 10 0.3× 36 1.3× 38 366
Georgia McCaughan Australia 10 82 0.8× 23 0.4× 13 0.4× 8 0.3× 32 1.2× 29 265
Kundan Mishra India 10 62 0.6× 67 1.1× 12 0.4× 7 0.2× 35 1.3× 88 412
H. Elkacemi Morocco 7 122 1.1× 69 1.2× 20 0.7× 4 0.1× 16 0.6× 30 282
Sanna‐Maria Kivivuori Finland 11 41 0.4× 35 0.6× 50 1.7× 6 0.2× 33 1.2× 21 262
Syed Hasan United States 8 41 0.4× 29 0.5× 8 0.3× 15 0.5× 15 0.6× 14 325
Di̇lek Erdem Türkiye 10 122 1.1× 15 0.3× 9 0.3× 16 0.6× 13 0.5× 38 267
Peter W. MacIntosh United States 10 40 0.4× 27 0.5× 68 2.3× 14 0.5× 34 1.3× 43 312

Countries citing papers authored by Michael Machiorlatti

Since Specialization
Citations

This map shows the geographic impact of Michael Machiorlatti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Machiorlatti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Machiorlatti more than expected).

Fields of papers citing papers by Michael Machiorlatti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Machiorlatti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Machiorlatti. The network helps show where Michael Machiorlatti may publish in the future.

Co-authorship network of co-authors of Michael Machiorlatti

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Machiorlatti. A scholar is included among the top collaborators of Michael Machiorlatti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Machiorlatti. Michael Machiorlatti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
George, Deepu, et al.. (2023). Intersection of Mental Health and Dysphonia: A Scoping Review. Journal of Voice. 39(5). 1418.e11–1418.e24. 1 indexed citations
3.
Machiorlatti, Michael, et al.. (2023). The Relationship Between Food Insecurity and Food Assistance Program Participation in Families of Preschool Children in the Rio Grande Valley. Journal of Hunger & Environmental Nutrition. 19(1). 67–85.
4.
Machiorlatti, Michael, et al.. (2023). Community Exercise Program Participation and Mental Well-Being in the U.S. Texas–Mexico Border Region. Healthcare. 11(22). 2946–2946.
5.
Machiorlatti, Michael, et al.. (2023). Diurnal variability of cortisol in the Pennsylvania adult smoking study: Exploration of association with nicotine intake. International Journal of Psychophysiology. 186. 24–32. 2 indexed citations
6.
Machiorlatti, Michael, et al.. (2023). An innovative approach to comprehensive communication skills training for residents: A resident-led communication curriculum. Journal of Investigative Medicine. 71(8). 813–820.
7.
Machiorlatti, Michael, et al.. (2022). Patterns of Colorectal Cancer in Texas Counties From 2000 to 2017. JCO Oncology Practice. 18(5). e770–e779. 2 indexed citations
8.
Heredia, Natalia I., Michael Machiorlatti, Belinda M. Reininger, & Candace Robledo. (2022). Factors associated with meeting physical activity guidelines during the COVID-19 pandemic. BMC Public Health. 22(1). 2178–2178. 3 indexed citations
9.
Desai, Sohum, et al.. (2022). Impact of Artificial Intelligence Stroke Software on Detection of LVO Transfer Patients (P17-10.010). Neurology. 98(18_supplement). 1 indexed citations
10.
Assi, Hussein, Adam S. Asch, Michael Machiorlatti, Sara K. Vesely, & Sami Ibrahimi. (2020). Development of Thrombocytopenia is Associated with Improved Survival in Patients Treated with Immunotherapy. Future Science OA. 6(7). FSO581–FSO581. 13 indexed citations
11.
Assi, Hussein, et al.. (2020). Predictors of Outcome in Patients With Fibrolamellar Carcinoma: Analysis of the National Cancer Database. Anticancer Research. 40(2). 847–855. 12 indexed citations
12.
Chen, Allshine, Michael Machiorlatti, Nicolle M. Krebs, & Joshua Muscat. (2019). Socioeconomic differences in nicotine exposure and dependence in adult daily smokers. BMC Public Health. 19(1). 375–375. 44 indexed citations
13.
Ibrahimi, Sami, et al.. (2017). Incidence of Vascular Thromboembolic Events in Patients Receiving Immunotherapy: A Single Institution Experience. Blood. 130. 4864–4864. 23 indexed citations
14.
Mukherjee, Sarbajit, et al.. (2017). Analysis of Outcome of Patients Treated with Anti PD-1/Pdl-1 Therapy According to the Degree of Lymphopenia. Blood. 130. 3594–3594. 2 indexed citations
15.
Machiorlatti, Michael, et al.. (2017). Outcomes and Prognostic Factors of Resected Salivary Gland Malignancies: Examining a Single Institution’s 12-year Experience. Anticancer Research. 37(9). 5019–5025. 9 indexed citations
16.
Srour, Samer A., Michael Machiorlatti, Mohamad Cherry, et al.. (2017). Impact of Health Care Insurance Status on Treatment Outcomes of Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 17(7). 450–456.e2. 7 indexed citations
17.
Rostaminia, Ghazaleh, Michael Machiorlatti, S. Abbās Shobeiri, & Lieschen H. Quiroz. (2016). Variability of the pubic arch architecture and its influence on the minimal levator hiatus area. International Journal of Gynecology & Obstetrics. 134(2). 217–220. 2 indexed citations
18.
Iqbal, Madiha, et al.. (2016). Impact of Duration of Neutropenia and Lymphopenia on AML Patients Undergoing Induction Chemotherapy. Blood. 128(22). 5178–5178. 4 indexed citations
19.
Couloures, Kevin, Michael P. Anderson, Michael Machiorlatti, Olivera Marsenić, & Lawrence M. Opas. (2016). Discontinuation of Antimicrobial Prophylaxis (AP) in Children With Spina Bifida: A Case Series Analysis. Nephro-Urology Monthly. 8(5). e38484–e38484. 4 indexed citations
20.
Machiorlatti, Michael, Sara K. Vesely, Samer A. Srour, et al.. (2014). Time from Hospital Admission to Induction Chemotherapy Adversely Affects Outcomes in Patients with Acute Myeloid Leukemia. Blood. 124(21). 1289–1289. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026